Harvard Bioscience Inc. (HBIO)
NASDAQ: HBIO
· Real-Time Price · USD
0.48
-0.05 (-9.06%)
At close: Aug 11, 2025, 3:59 PM
-9.06% (1D)
| Bid | 0.36 |
| Market Cap | 21.2M |
| Revenue (ttm) | 91.4M |
| Net Income (ttm) | -58.05M |
| EPS (ttm) | -1.31 |
| PE Ratio (ttm) | -0.37 |
| Forward PE | 8.62 |
| Analyst | Hold |
| Ask | 0.58 |
| Volume | 881,869 |
| Avg. Volume (20D) | 12,320,791 |
| Open | 0.51 |
| Previous Close | 0.53 |
| Day's Range | 0.47 - 0.53 |
| 52-Week Range | 0.28 - 3.27 |
| Beta | 1.55 |
About HBIO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol HBIO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for HBIO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Harvard Bioscience Inc. is scheduled to release its earnings on
Aug 11, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
4 weeks ago
Harvard Bioscience shares are trading higher after...
Unlock content with
Pro Subscription
3 months ago
Harvard Bioscience shares are trading higher after the company reported better-than-expected Q1 financial results.
3 months ago · seekingalpha.com
Harvard Bioscience, Inc. (HBIO) Q1 2025 Earnings Call TranscriptHarvard Bioscience, Inc. (NASDAQ:HBIO ) Q1 2025 Earnings Conference Call May 12, 2025 8:00 AM ET Company Participants Kathryn Flynn - Corporate Controller Jim Green - Chairman, President & CEO Mark Fr...